Canon J G
Psychopharmacology (Berl). 1979 Jun 28;64(1):55-60. doi: 10.1007/BF00427345.
Clozapine (0.16--10 mg/kg, p. o.), chlorpromazine (0.25--2 mg/kg, p. o.), and thioridazine (0.25--2 mg/kg, p. o.) were administered to squirrel monkeys subjected to a DRL 10 s schedule. The reinforcer consisted of 50% unsweetened orange juice. Chlorpromazine and thioridazine had no effect at the lower doses, but decreased response rate at the highest dose. Clozapine increased response rates at the low doses (0.31--2.5 mg/kg) and decreased rates at the high dose (10 mg/kg). Clozapine appears to show a major difference from other neuroleptic drugs in this test by increasing response rate. Since clozapine produces few extrapyramidal side effects in man, this procedure may be useful in selecting and developing new anti-psychotic drugs with less liability for side effects.
对接受固定间隔10秒强化程序的松鼠猴给予氯氮平(0.16 - 10毫克/千克,口服)、氯丙嗪(0.25 - 2毫克/千克,口服)和硫利达嗪(0.25 - 2毫克/千克,口服)。强化物为50%的无糖橙汁。氯丙嗪和硫利达嗪在低剂量时无作用,但在最高剂量时降低反应率。氯氮平在低剂量(0.31 - 2.5毫克/千克)时增加反应率,在高剂量(10毫克/千克)时降低反应率。在该试验中,氯氮平似乎与其他抗精神病药物有显著差异,它能提高反应率。由于氯氮平在人体中几乎不产生锥体外系副作用,该程序可能有助于筛选和开发副作用较小的新型抗精神病药物。